Frequency and Natural History of Emergency General Surgery Conditions in Cancer Patients

医学 乳腺癌 肺癌 癌症 前列腺癌 入射(几何) 累积发病率 内科学 比例危险模型 肿瘤科 队列 外科 物理 光学
作者
Joshua S. Jolissaint,Stephanie Lobaugh,Debra A. Goldman,Sarah M. McIntyre,Elvira L. Vos,Katherine S. Panageas,Alice C. Wei
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1097/sla.0000000000006554
摘要

Objective: To determine if cancer patients experience variability in incidence or management of emergency general surgery (EGS) conditions compared to non-cancer patients. Background: The true frequency, and natural history of EGS conditions among cancer patients has not been characterized. Methods: We utilized SEER-Medicare data from January 2006–December 2015 to compare patients with breast, prostate, and lung cancer to a non-cancer cohort. Patients were followed from date of cancer diagnosis, or an index date for non-cancer patients, to the development of an EGS condition, death or last follow up. We assessed the cumulative incidence of EGS conditions over time, and fit multivariable Cox proportional hazards models to evaluate the impact of time-dependent surgical intervention on mortality. Results: We identified 322,756 patients with breast (N=82,147), lung (N=128,618), and prostate cancer (N=111,991) and 210,429 non-cancer patients.. Cancer patients had a higher incidence of an EGS condition within the first year after diagnosis (4.8% vs. 3.2%), with lung (6.8%) and breast cancer (4.0%) showing consistent rends. Cancer patients were less likely to undergo surgery for (13% vs. 14%, P =0.005), though this varied by cancer type and EGS conditions. Patients with breast (HR 1.27, 95%CI 1.17-1.39) and lung cancer (HR 3.27, 95%CI 3.07-3.48) were more likely to die within 30-days of an EGS diagnosis. Conclusions: Cancer patients experience a higher incidence of EGS conditions within the first year following diagnosis, but are less likely to undergo surgery. Future research is needed to explore the interplay between EGS conditions, their management, and receipt of intended oncologic therapy, and resulting outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
石友瑶发布了新的文献求助10
1秒前
zouni完成签到,获得积分10
1秒前
1秒前
团子完成签到,获得积分10
2秒前
2秒前
3秒前
小卡拉米发布了新的文献求助10
3秒前
4秒前
5秒前
北北关注了科研通微信公众号
6秒前
小逗比完成签到,获得积分10
7秒前
乐乐应助科研通管家采纳,获得10
8秒前
CipherSage应助科研通管家采纳,获得10
8秒前
小二郎应助科研通管家采纳,获得10
8秒前
浮游应助科研通管家采纳,获得10
8秒前
明理的绿蓉完成签到,获得积分10
8秒前
科研通AI2S应助科研通管家采纳,获得30
8秒前
香蕉觅云应助科研通管家采纳,获得20
8秒前
Lucas应助科研通管家采纳,获得10
8秒前
雨归完成签到 ,获得积分10
8秒前
wanci应助科研通管家采纳,获得10
8秒前
浮游应助科研通管家采纳,获得10
8秒前
酷波er应助科研通管家采纳,获得10
8秒前
科研通AI6应助科研通管家采纳,获得10
8秒前
Nailuokk应助科研通管家采纳,获得10
9秒前
研友_VZG7GZ应助科研通管家采纳,获得10
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
慕青应助科研通管家采纳,获得10
9秒前
浮游应助科研通管家采纳,获得10
9秒前
闪闪涫应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
9秒前
9秒前
笨笨凡松发布了新的文献求助10
10秒前
快乐的小凡完成签到,获得积分10
11秒前
12秒前
14秒前
无极微光应助灿灿采纳,获得20
14秒前
英姑应助陈陈采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
Psychology of Self-Regulation 600
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5638086
求助须知:如何正确求助?哪些是违规求助? 4744566
关于积分的说明 15001034
捐赠科研通 4796214
什么是DOI,文献DOI怎么找? 2562406
邀请新用户注册赠送积分活动 1521889
关于科研通互助平台的介绍 1481759